Skip to main content
Thomas Uldrick Jr., MD, Oncology, Seattle, WA, Fred Hutchinson Cancer Center

ThomasUldrickJr.MD

Oncology Seattle, WA

Deputy Head, Global Oncology

Dr. Uldrick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Uldrick's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2002

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2017 - 2024
  • NY State Medical License
    NY State Medical License 2004 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNA  
    Ramya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences
  • International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease  
    Aaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood

Abstracts/Posters

  • High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
    Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIV
    Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...
    Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Phase I study of pembrolizumab in people with HIV and cancer. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early MortalityClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Exploring Why People with HIV Have a Higher Risk of Lung Cancer
    Exploring Why People with HIV Have a Higher Risk of Lung CancerDecember 4th, 2018
  • Doctor Has Been in Remission for FIVE YEARS After Testing Drug on Himself
    Doctor Has Been in Remission for FIVE YEARS After Testing Drug on HimselfAugust 16th, 2019
  • Penn Researchers Discover Key Mechanism of Cytokine Storm in Castleman Disease
    Penn Researchers Discover Key Mechanism of Cytokine Storm in Castleman DiseaseMay 7th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations